Register for your FREE account now and join the thousands of healthcare professionals who have depended on us for over 26 years for accurate, concise, and timely drug information.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Nimodipine Capsules

Compare to Similar Drugs | Add to Clipboard | View Clipboard | Print | Email

Close [X]

Compare Nimodipine Capsules to:

Generic Name for Nimodipine Capsules

Nimodipine 30mg; soft-gel caps.

Legal Classification:

Pharmacological Class for Nimodipine Capsules

Calcium channel blocker.

Manufacturer of Nimodipine Capsules

Various generic manufacturers

Indications for Nimodipine Capsules

To improve neurological outcome of subarachnoid hemorrhage from ruptured intracranial berry aneurysms, regardless of post-ictus neurological condition.

Adult dose for Nimodipine Capsules

Take on empty stomach. 60mg every 4 hours for 21 consecutive days. Start within 96 hours of subarachnoid hemorrhage. If oral therapy is not feasible, may extract capsule contents into a syringe and give via in situ NG tube, then flush tube with normal saline. Hepatic impairment: 30mg every 4 hours; monitor.

Children's dosing for Nimodipine Capsules

Not recommended.

Warnings/Precautions for Nimodipine Capsules

Not for IV or other parenteral administration (may be fatal). Hepatic impairment. Monitor BP, heart rate. Pregnancy (Cat.C). Nursing mothers: not recommended.

Interactions for Nimodipine Capsules

May potentiate other calcium channel blockers. Potentiated by cimetidine.

Adverse Reactions for Nimodipine Capsules

Decreased blood pressure, GI upset, headache, bradycardia, flushing, edema, rash; rare: intestinal pseudo-obstruction and ileus.

Notes for Nimodipine Capsules

Formerly known under the brand name Nimotop.

How is Nimodipine Capsules supplied?

Contact supplier.

Related Disease:

Intracranial berry aneurysms

Subarachnoid hemorrhage

Causality Link Between HDL Cholesterol, MI Challenged

May 17, 2012

Genetic mechanisms that are associated with high plasma levels of high-density lipoprotein (HDL) cholesterol do not reduce the risk of myocardial infarction (MI), adding question to causality of link.

Statins Benefit Those at Low Risk for Vascular Events

May 17, 2012

Reduction of low-density lipoprotein (LDL) cholesterol with statins is associated with a decrease in major vascular events, even for individuals with a five-year risk of <10%.

Coffee Drinking Linked to Lower Mortality Risk

May 17, 2012

Coffee drinking is associated with a lower risk of death from most major causes except cancer.

Repeated Revascularization Doesn't Aid High-Risk Patients

May 16, 2012

For asymptomatic patients who are identified as high-risk by exercise echocardiography (ExE) after coronary revascularization, repeated revascularization is not associated with improved outcomes.

Trail Making Test Performance Predicts Post-Stroke Mortality

May 15, 2012

Poor executive performance, as measured with the Trail Making Test (TMT)-A and -B, can identify elderly men who are at higher risk of death after a first-ever stroke.